|
|
 |
|
Viewing report
|
|
|
|
Breast Cancer Insight - Defining Drug Decisions - How Can Companies Influence the Treatment of Breast Cancer?
Datamonitor, April 2002, Pages: 548
Based on extensive interviews with breast cancer-treating specialists in the seven major markets, Breast Cancer Insight is a barometer of physicians’ perceptions and prescribing trends. The quantitative and qualitative nature of the Breast Cancer Insight study data provides a full and impartial perspective on the breast cancer market.Over 580 interviews with practising cancer specialists - oncologist,surgeons, radiologists, and gynecologistsRespondents in the 7 major markets - 101 in the USA, and 80 in each of France, Germany, Italy, Spain, UK, and JapanInvestigation of screening and diagnosis techniquesFocus on therapy types: chemotherapies, hormonals, innovatives and adjunct therapiesAnalysis and discussion of survey results from each of the 7 major marketsSelective direction of promotional budget will benefit manufacturersMore comprehensive clinical trial data is needed to convince prescribers.Growth in the market is expected to be driven not only by the rising incidence of breast cancer, but also by the increasing use of chemotherapy in first line treatment.Identify key issues for practicing cancer specialists - the questions they really want the pharma industry to answerExplore the reasons, rational and emotional, behind cancer specialists' decisionsPredict future trends and perception in the treatment of breast cancer patientsPlan new drug development to meet patient management requirements
Customers who bought this item also bought
Stakeholder Insight: Adjunct Therapies in Breast Cancer
Stakeholder Insight: The Screening and Diagnosis of Breast Cancer
Stakeholder Insight: Hormonal Therapies in Breast Cancer
Treatment Algorithms 2001 Breast Cancer: Herceptin Falling into Stride
Drugs of Tommorow 2002: Breast Cancer
Stakeholder Insight: Breast Cancer Chemotherapy
Drugs of Tomorrow: Cancer Overview - The synergistic advance: innovatives compliment traditional chemotherapies
Bisphosphonates Update - The Treatment and Prevention of Bone Metastases in Breast and Prostate Cancer
Strategic Perspectives 2001: Breast Cancer Cost Analysis
Pipeline Insight: Breast Cancer - Recent Approvals Increase Pressure On Pipeline Candidates
Cancer Drug Discoveries: What the Future Holds: Breast Cancer Chapter
U.S. Breast Cancer Therapeutics Markets
|
|
|
|
